Commissione, Europea

mAbxience annuncia l'approvazione da parte della Commissione Europea dei biosimilari di Denosumab

Published on 08/07/2025 at 18:06 | prnewswire.co.uk

mAbxience Italy United States of America Austria Belgium France Germany Netherlands Spain Switzerland United Kingdom

View original content:https://www.prnewswire.com/it/comunicati-stampa/mabxience-annuncia-lapprovazione-da-parte-della-commissione-europea-dei-biosimilari-di-denosumab-302496774.html

en | boerse | 67954929 |